These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28561435)

  • 1. Comparing methods for fetal fraction determination and quality control of NIPT samples.
    van Beek DM; Straver R; Weiss MM; Boon EMJ; Huijsdens-van Amsterdam K; Oudejans CBM; Reinders MJT; Sistermans EA
    Prenat Diagn; 2017 Aug; 37(8):769-773. PubMed ID: 28561435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open source non-invasive prenatal testing platform and its performance in a public health laboratory.
    Johansen P; Richter SR; Balslev-Harder M; Miltoft CB; Tabor A; Duno M; Kjaergaard S
    Prenat Diagn; 2016 Jun; 36(6):530-6. PubMed ID: 27027563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total number of reads affects the accuracy of fetal fraction estimates in NIPT.
    Miceikaitė I; Brasch-Andersen C; Fagerberg C; Larsen MJ
    Mol Genet Genomic Med; 2021 Apr; 9(4):e1653. PubMed ID: 33687149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts.
    Kim SK; Hannum G; Geis J; Tynan J; Hogg G; Zhao C; Jensen TJ; Mazloom AR; Oeth P; Ehrich M; van den Boom D; Deciu C
    Prenat Diagn; 2015 Aug; 35(8):810-5. PubMed ID: 25967380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with non-invasive prenatal screening for single-gene disorders.
    Mohan P; Lemoine J; Trotter C; Rakova I; Billings P; Peacock S; Kao CY; Wang Y; Xia F; Eng CM; Benn P
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):33-39. PubMed ID: 34358384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated With Informative Redraw After an Initial No Result in Noninvasive Prenatal Testing.
    Benn P; Valenti E; Shah S; Martin K; Demko Z
    Obstet Gynecol; 2018 Aug; 132(2):428-435. PubMed ID: 29995728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Single-Nucleotide Polymorphism-Based Fetal Fraction Estimation of Maternal Plasma Circulating Cell-Free DNA Using Bayesian Hierarchical Models.
    Larson NB; Wang C; Na J; Rowsey RA; Highsmith WE; Hoppman NL; Kocher JP; Klee EW
    J Comput Biol; 2018 Sep; 25(9):1040-1049. PubMed ID: 29932737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of determining the limit of detection of non-invasive prenatal testing methods.
    Fiorentino F; Bono S; Pizzuti F; Mariano M; Polverari A; Duca S; Sessa M; Baldi M; Diano L; Spinella F
    Prenat Diagn; 2016 Apr; 36(4):304-11. PubMed ID: 26815144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy.
    Suzumori N; Sekizawa A; Ebara T; Samura O; Sasaki A; Akaishi R; Wada S; Hamanoue H; Hirahara F; Izumi H; Sawai H; Nakamura H; Yamada T; Miura K; Masuzaki H; Yamashita T; Okai T; Kamei Y; Namba A; Murotsuki J; Tanemoto T; Fukushima A; Haino K; Tairaku S; Matsubara K; Maeda K; Kaji T; Ogawa M; Osada H; Nishizawa H; Okamoto Y; Kanagawa T; Kakigano A; Kitagawa M; Ogawa M; Izumi S; Katagiri Y; Takeshita N; Kasai Y; Naruse K; Neki R; Masuyama H; Hyodo M; Kawano Y; Ohba T; Ichizuka K; Nagamatsu T; Watanabe A; Shirato N; Yotsumoto J; Nishiyama M; Hirose T; Sago H
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():165-169. PubMed ID: 29605711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal fraction-based risk algorithm for non-invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell-free fetal DNA.
    McKanna T; Ryan A; Krinshpun S; Kareht S; Marchand K; Grabarits C; Ali M; McElheny A; Gardiner K; LeChien K; Hsu M; Saltzman D; Stosic M; Martin K; Benn P
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):73-79. PubMed ID: 30014528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of combinatorial probe-anchor ligation-based sequencing as non-invasive prenatal test for trisomy at a central laboratory.
    Ma J; Wang Y; Wang W; Dong Y; Xu C; Zhou A; Xu Z; Wu Z; Tang X; Chen F; Yin Y; Wang W; Yan M; Zhang W; Mu F; Yang H
    Ultrasound Obstet Gynecol; 2017 Jul; 50(1):49-57. PubMed ID: 27363706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proof-of-concept study on the effects of low total cfDNA content and solutions to increase the NIPT trisomy 21 detection rate.
    Du Y; Chen A; Yang R; Zhou T; Zhou Q; Yang L; Wang J; Hong Y; Chen C; Wan Q; Yang L; Chen Y
    J Clin Lab Anal; 2020 Feb; 34(2):e23035. PubMed ID: 31568605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing. Initial experience in Mexican women and literature review].
    Hernández-Gómez M; Ramirez-Arroyo E; Meléndez-Hernández R; Garduño-Zaraza LM; Mayén-Molina DG
    Ginecol Obstet Mex; 2015 May; 83(5):277-88. PubMed ID: 26233973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-Free DNA-Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis.
    Nshimyumukiza L; Beaumont JA; Duplantie J; Langlois S; Little J; Audibert F; McCabe C; Gekas J; Giguère Y; Gagné C; Reinharz D; Rousseau F
    J Obstet Gynaecol Can; 2018 Jan; 40(1):48-60. PubMed ID: 28784564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies.
    Li R; Wan J; Zhang Y; Fu F; Ou Y; Jing X; Li J; Li D; Liao C
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):53-7. PubMed ID: 26033469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of chromosome abnormalities using current noninvasive prenatal testing: A multi-center comparative study.
    Du Y; Lin J; Lan L; Dong Y; Zhu J; Jiang W; Pan X; Lu Y; Li D; Wang L
    Biosci Trends; 2018 Jul; 12(3):317-324. PubMed ID: 29952350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant non-invasive prenatal testing (NIPT) - a systematic review.
    Hartwig TS; Ambye L; Sørensen S; Jørgensen FS
    Prenat Diagn; 2017 Jun; 37(6):527-539. PubMed ID: 28382695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calculating the fetal fraction for noninvasive prenatal testing based on genome-wide nucleosome profiles.
    Straver R; Oudejans CB; Sistermans EA; Reinders MJ
    Prenat Diagn; 2016 Jul; 36(7):614-21. PubMed ID: 26996738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Invasive Prenatal Testing (NIPT) in pregnancies with trisomy 21, 18 and 13 performed in a public setting - factors of importance for correct interpretation of results.
    Hartwig TS; Ambye L; Werge L; Weiergang MK; Nørgaard P; Sørensen S; Jørgensen FS
    Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():35-39. PubMed ID: 29804026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.